Adventia NIPD GENETICS Carrier Screening Logo (WIPO, 12.06.2020)
WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke Adventia NIPD GENETICS Carrier Screening wurde als Bildmarke am 12.06.2020 bei der Weltorganisation für geistiges Eigentum angemeldet.
Logodesign (Wiener Klassifikation)
#Briefe, die eine besondere Form des Schreibens darstellen #Farben #Serie von Briefen, die verschiedene Formen des Schreibens darstellen #Buchstabenreihen in verschiedenen Dimensionen #Zwei vorherrschende Farben
| Markenform | Bildmarke |
| Aktenzeichen | 1544123 |
| Registernummer | 018191796 |
| Länder | 
|
| Basismarke |
Nr. 018191796,
03. Juni 2020
|
| Anmeldedatum | 12. Juni 2020 |
| Ablaufdatum | 12. Juni 2030 |
Markeninhaber
31, Neas Engomis, Engomi
2409 Nicosia
CY
2409 Nicosia
CY
Markenvertreter
2-4, Arch. Makaros III Avenue,
Capital Center, 7th floor
CY
Waren und Dienstleistungen
01
Kits composed of reagents for genetic testing for medical
and scientific research purposes; kits composed of reagents
for genetic testing for medical and scientific research
purposes in the field of human reproduction; kits composed
of reagents for testing prospective parents for medical and
scientific research purposes; kits composed of reagents for
testing the carrier status of prospective parents for gene
mutations with or without evident phenotype for medical and
scientific research purposes
42
Medical laboratory services for carrier testing of
prospective parents for genetic abnormalities; design and
development of medical screening tests and products; medical
and scientific research in the field of genetic testing;
providing medical and scientific research information in the
field of genetic testing; genetic testing for scientific
research and analysis purposes in the field of human
reproduction; carrier testing of prospective parents for
scientific research purposes; testing for sub-chromosomal
abnormalities and genetic mutations in prospective parents
for research purposes; scientific, laboratory, clinical,
medical, and technological research and analysis services in
the fields of genetic testing in prospective parents
44
Medical postnatal testing services for screening of
prospective parents for genetic abnormalities; medical
genetic screening testing of prospective parents; medical
testing of biological material for screening prospective
parents for genetic abnormalities prior to pregnancy;
medical testing of buccal swab for screening of the carrier
status for genetic abnormalities in prospective parents;
genetic testing and genetic counseling in the field of human
reproduction; medical and health services relating to dna,
genetics and genetic testing
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 05. August 2021 | 2021/31 Gaz | JP | Ablehnung |
| 26. Juli 2021 | 2021/30 Gaz | UA | Ablehnung |
| 01. Juli 2021 | 2021/27 Gaz | US | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 17. März 2021 | 2021/13 Gaz | SG | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 08. März 2021 | 2021/10 Gaz | IN | Ablehnung |
| 05. März 2021 | 2021/10 Gaz | IL | Ablehnung |
| 01. März 2021 | 2021/9 Gaz | RU | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 04. Februar 2021 | 2021/6 Gaz | RS | Ablehnung |
| 23. Dezember 2020 | 2020/53 Gaz | TR | Ablehnung |
| 27. November 2020 | 2020/50 Gaz | RU | Ablehnung |
| 31. Oktober 2020 | 2020/45 Gaz | SG | Ablehnung |
| 01. Oktober 2020 | 2020/40 Gaz | US | Ablehnung |
| 12. Juni 2020 | 2020/30 Gaz | EM | Eintragung |
ID: 141544123